Insulin Resistance And End Stage Renal Disease: The Role Of Retinol Binding Protein 4

• Conditions: End Stage Renal Disease; Insulin Resistance; Diabetes

• Registration Number: NCT00910130
• Lead Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

Brief Summary

The purpose of this study is to determine whether Retinol binding protein 4 has a role in insulin resistance development in patients suffering from end stage renal disease on hemodialysis.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07
• Status Verified: 2009-05
• Study First Submitted: 2009-05-28
• Study First Submitted QC: 2009-05-28
• Last Update Submitted: 2009-05-28
• Study First Posted: 2009-05-29
• Last Update Posted: 2009-05-29

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Hemodialysis for "End Stage Renal Disease group"
• Normal Renal Function for "Control group"

Exclusion Criteria

• Diabetes
• Malnutrition
• Malignancy
• Acute Infection
• Chronic Active Infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Giovanni Piotti; 🇮🇹 Pavia, Italy